O'Reilly, E. M., Roach, J., Miller, P., Yu, K. H., Tjan, C., Rosano, M., . . . Ryan, D. P. (2017). Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab‐Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results. Oncologist.
Chicago-tyylinen lähdeviittausO'Reilly, Eileen M., et al. "Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined With Nab‐Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer: Phase I Results." Oncologist 2017.
MLA-viiteO'Reilly, Eileen M., et al. "Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined With Nab‐Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer: Phase I Results." Oncologist 2017.